Research Topics
| Danny ZiprisSummaryAffiliation: University of Colorado Denver Country: USA Publications
| Collaborators
|
Detail Information
Publications
Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetesAimon K Alkanani
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
Diabetes 61:2525-33. 2012..Our data may imply that alterations in innate immune pathways are detectable in genetically susceptible individuals and could be linked with the early course of T1D...
Toll-like receptors and type 1 diabetesDanny Zipris
Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO 80045, USA
Adv Exp Med Biol 654:585-610. 2010..The new knowledge about the role of innate immune pathways in triggering islet destruction could lead to the discovery of new molecules that may be targeted for disease prevention...
Innate immunity in type 1 diabetesDanny Zipris
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
Diabetes Metab Res Rev 27:824-9. 2011..We have used the biobreeding diabetes resistant and LEW1.WR1 rat models to identify the role of virus-induced innate immunity in the mechanism of type 1 diabetes...
The role of the intestinal microbiota in type 1 diabetesNaoko Hara
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
Clin Immunol 146:112-9. 2013..A better understanding of the interplay between microbes and innate immune pathways in early disease stages holds promise for the design of immune interventions and disease prevention in genetically susceptible individuals...
Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetesPilar Londono
Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO 80045, USA
Clin Immunol 135:401-11. 2010....
Prevention of virus-induced type 1 diabetes with antibiotic therapyNaoko Hara
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
J Immunol 189:3805-14. 2012..The data suggest that gut microbiota may be involved in promoting virus-induced T1D in the LEW1.WR1 rat model...
Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanismsDanny Zipris
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO 80045 6511, USA
Clin Immunol 131:11-23. 2009..Understanding the link between environmental agents and innate immune pathways involved in early stages of diabetes may advance the design of immune interventions to prevent disease in genetically susceptible individuals...
DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced autoimmune diabetesTravis R Wolter
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, 1775 Aurora Ct, Mail Stop B 140, Aurora, CO 80045, USA
Clin Immunol 132:103-15. 2009..Our findings provide new insights into KRV-induced innate immune pathways that may play a role in early mechanisms leading to islet inflammation and diabetes...
Altered Toll-like receptor signaling pathways in human type 1 diabetesAdam J Meyers
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Ct, Mail Stop B 140, Aurora, CO 80045, USA
J Mol Med (Berl) 88:1221-31. 2010..Taken together, our observations provide evidence that altered innate immunity exists in mDCs and pDCs from T1D and raise the possibility that these alterations may be associated with disease mechanisms...
Innate immunity and its role in type 1 diabetesDanny Zipris
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, Colorado 80045 6511, USA
Curr Opin Endocrinol Diabetes Obes 15:326-31. 2008..This review focuses on recent studies on the role of Toll-like receptors and innate pathways in triggering type 1 diabetes...
